Nasal Pharmaceutical Formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140194400A1
SERIAL NO

14122561

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a nasel formulation comprising as its active ingredient an intranasal corticosteroid, and also to a method for prophylaxis or treatment of seasonal or perennial allergic and non-allergic rhinitis and rhinoconjunctivitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDA PHARMA GMBH & CO KG61352 BAD HOMBURG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hildebrand-Cyrener, Annegret Radebeul, DE 2 1
Maus, Joachim Muehlheim am Main, DE 19 157
Munzel, Ullrich Woellstadt, DE 2 18
Tritschler, Hans Muenchen, DE 1 1
Weingart, Mario Dresden, DE 6 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation